肠杆菌素结合疫苗对鸡大肠杆菌病的免疫原性与保护效果评价
本研究以白来航鸡为对象,采用疫苗接种与APEC攻毒(O1、O78或PBS对照)交叉设计分六组(每组9至10只),7日龄皮下接种肠杆菌素结合疫苗100 μg/只、21日龄加强,28日龄气管攻毒108 CFU/只,攻毒后5天剖检。疫苗使血清肠杆菌素特异性IgY升高64倍,显著降低O78攻毒鸡的病变评分,但未显著降低所检器官的APEC载量,并改变了回肠与盲肠菌群。
要点
- 肠杆菌素结合疫苗使血清肠杆菌素特异性IgY升高64倍。
- O78攻毒后疫苗组肺、气囊、心、肝、脾病变评分显著低于对照组。
- 疫苗未显著降低所检器官APEC载量,但改变了回肠与盲肠菌群。
核心结论
- 肠杆菌素结合疫苗可触发强特异性免疫反应,有希望为鸡提供抗APEC感染的保护。
研究设计与样本
- 白来航鸡采用疫苗接种(有或无)与APEC攻毒(O1、O78或PBS对照)两变量交叉设计,共六组,每组9至10只。
- 7日龄皮下接种肠杆菌素结合疫苗100 μg/只,21日龄加强免疫,28日龄气管攻毒108 CFU/只或PBS,攻毒后5天剖检主要器官病变与APEC定植。
主要发现
- 免疫鸡血清肠杆菌素特异性IgY水平升高64倍。
- 高毒力O78攻毒引起肺、气囊、心、肝、脾广泛病变,疫苗组病变评分显著降低。
- 疫苗接种未显著降低所检器官的APEC水平。
- 低毒力O1在疫苗组与对照组均仅引起器官散发病变。
- 肠杆菌素结合疫苗改变了回肠与盲肠的细菌群落。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Colibacillosis is one of the most common and economically devastating infectious diseases in poultry production worldwide. Innovative universal vaccines are urgently needed to protect chickens from the infections caused by genetically diverse avian pathogenic Escherichia coli (APEC). Enterobactin (Ent) is a highly conserved siderophore required for E. coli iron acquisition and pathogenesis. The Ent-specific antibodies induced by a novel Ent conjugate vaccine significantly inhibited the in vitro growth of diverse APEC strains. In this study, White Leghorn chickens were immunized with the Ent conjugate vaccine using a crossed design with two variables, vaccination (with or without) and APEC challenge (O1, O78, or PBS control), resulting in six study groups (9 to 10 birds/group). The chickens were subcutaneously injected with the vaccine (100 μg per bird) at 7 days of age, followed by booster immunization at 21 days of age. The chickens were intratracheally challenged with an APEC strain (108 CFU/bird) or PBS at 28 days of age. At 5 days post infection, all chickens were euthanized to examine lesions and APEC colonization of the major organs. Immunization of chickens with the Ent vaccine elicited a strong immune response with a 64-fold increase in the level of Ent-specific IgY in serum. The hypervirulent strain O78 caused extensive lesions in lung, air sac, heart, liver, and spleen with significantly reduced lesion scores observed in the vaccinated chickens. Interestingly, the vaccination did not significantly reduce APEC levels in the examined organs. The APEC O1 with low virulence only caused sporadic lesions in the organs in both vaccination and control groups. The Ent conjugate vaccine altered the bacterial community of the ileum and cecum. Taken together, the findings from this study showed the Ent conjugate vaccine could trigger a strong specific immune response and was promising to confer protection against APEC infection.
引用
- Wang H, Cao L, Logue CM, et al. Evaluation of immunogenicity and efficacy of the enterobactin conjugate vaccine in protecting chickens from colibacillosis. Vaccine. 2022. PMID: 36585279. doi:10.1016/j.vaccine.2022.12.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。